📊 STME Key Takeaways
Is Stimcell Energetics Inc. (STME) a Good Investment?
Stimcell Energetics is technically insolvent with negative stockholders equity of -$1.7M against only $34.5K in assets and zero revenue. The company is burning cash at -$268.6K annually with only $10.3K in reserves, creating acute bankruptcy risk within months absent emergency financing or asset acquisition.
Why Buy Stimcell Energetics Inc. Stock? STME Key Strengths
- Medical instruments sector could retain strategic value if company restructured or acquired
- Minimal debt burden relative to equity deficit
- Currently filing reports indicates ongoing corporate entity status
STME Stock Risks: Stimcell Energetics Inc. Investment Risks
- Insolvency - liabilities ($1.7M) far exceed assets ($34.5K); negative equity of -$1.7M
- Zero revenue and sustained operating losses of -$665.9K with no business generation
- Acute liquidity crisis - current ratio 0.02x with only $10.3K cash against $1.7M liabilities; cash will deplete within weeks at current burn rate
- Bankruptcy risk is imminent without emergency financing, merger, or significant operational turnaround
- OTC trading with minimal transparency and insider activity absent
Key Metrics to Watch
- Cash position and monthly burn rate (survival timeline critical)
- Revenue generation restart (currently zero)
- Stockholders equity trajectory (currently -$1.7M)
- Any financing announcements, mergers, or asset acquisitions
- Debt covenant defaults or creditor actions
Stimcell Energetics Inc. (STME) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
STME Profit Margin, ROE & Profitability Analysis
STME vs Healthcare Sector: How Stimcell Energetics Inc. Compares
How Stimcell Energetics Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Stimcell Energetics Inc. Stock Overvalued? STME Valuation Analysis 2026
Based on fundamental analysis, Stimcell Energetics Inc. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Stimcell Energetics Inc. Balance Sheet: STME Debt, Cash & Liquidity
STME Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Stimcell Energetics Inc.'s revenue has remained relatively flat over the 5-year period, with a 0% decline. The most recent EPS of $-0.01 indicates the company is currently unprofitable.
STME Revenue Growth, EPS Growth & YoY Performance
STME Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2024 | N/A | -$17.5K | $0.00 |
| Q2 2021 | $1.9K | -$189.3K | N/A |
| Q1 2021 | $1.5K | -$201.2K | N/A |
| Q3 2020 | N/A | -$144.3K | N/A |
| Q2 2020 | N/A | -$127.5K | N/A |
| Q1 2020 | N/A | -$243.5K | N/A |
| Q3 2015 | $5.3K | -$4.4K | N/A |
| Q1 2013 | N/A | N/A | N/A |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Stimcell Energetics Inc. Dividends, Buybacks & Capital Allocation
STME SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Stimcell Energetics Inc. (CIK: 0001493712)
📋 Recent SEC Filings
❓ Frequently Asked Questions about STME
What is the AI rating for STME?
Stimcell Energetics Inc. (STME) has an AI rating of STRONG SELL with 95% confidence, based on fundamental analysis of SEC EDGAR filings.
What are STME's key strengths?
Claude: Medical instruments sector could retain strategic value if company restructured or acquired. Minimal debt burden relative to equity deficit.
What are the risks of investing in STME?
Claude: Insolvency - liabilities ($1.7M) far exceed assets ($34.5K); negative equity of -$1.7M. Zero revenue and sustained operating losses of -$665.9K with no business generation.
What is STME's revenue and growth?
Stimcell Energetics Inc. reported revenue of $0.0.
Does STME pay dividends?
Stimcell Energetics Inc. does not currently pay dividends.
Where can I find STME SEC filings?
Official SEC filings for Stimcell Energetics Inc. (CIK: 0001493712) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is STME's EPS?
Stimcell Energetics Inc. has a diluted EPS of $0.00.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is STME a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Stimcell Energetics Inc. has a STRONG SELL rating with 95% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is STME stock overvalued or undervalued?
Valuation metrics for STME: ROE of N/A (sector avg: 15%), net margin of N/A (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy STME stock in 2026?
Our dual AI analysis gives Stimcell Energetics Inc. a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is STME's free cash flow?
Stimcell Energetics Inc.'s operating cash flow is $-268.6K, with capital expenditures of $0.0.
How does STME compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin N/A (avg: 12%), ROE N/A (avg: 15%), current ratio 0.02 (avg: 2).